Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,332 | 754 | 5,286 | 3,560 | 2,381 |
| Depreciation Amortization | 109 | 45 | 64 | 48 | 32 |
| Income taxes - deferred | 31 | 5 | -11 | 0 | 1 |
| Accounts receivable | 2,959 | 3,072 | 78 | 38 | 1,178 |
| Other Working Capital | 1,879 | 3,117 | -916 | -287 | 1,358 |
| Other Operating Activity | -2,950 | -3,068 | 34 | 69 | -1,073 |
| Operating Cash Flow | $3,360 | $3,925 | $4,536 | $3,428 | $3,878 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -826 | -1,006 | -1,847 | -1,607 | -2,847 |
| PPE Investments | 1 | 1 | N/A | N/A | N/A |
| Investing Cash Flow | $-825 | $-1,005 | $-1,847 | $-1,607 | $-2,847 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 169 | 66 | 30 | 10 | 0 |
| Common Stock Repurchased | -751 | -81 | -675 | -608 | -397 |
| Other Financing Activity | 1,263 | 405 | 197 | 0 | 0 |
| Financing Cash Flow | $681 | $390 | $-448 | $-598 | $-397 |
| Beginning Cash Position | 5,625 | 5,625 | 3,384 | 3,384 | 3,384 |
| End Cash Position | 8,841 | 8,935 | 5,625 | 4,607 | 4,018 |
| Net Cash Flow | $3,216 | $3,310 | $2,241 | $1,223 | $634 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,360 | 3,925 | 4,536 | 3,428 | 3,878 |
| Free Cash Flow | 3,360 | 3,925 | 4,536 | 3,428 | 3,878 |